KPTI - Karyopharm Therapeutics Inc. (KPTI) CEO Michael Kauffman on Q4 2018 Results - Earnings Call Transcript
Karyopharm Therapeutics Inc. (KPTI)
Q4 2018 Earnings Conference Call
February 28, 2019 8:30 AM ET
Company Participants
Ian Karp - Vice President, Investor and Public Relations
Michael Kauffman - Chief Executive Officer
Mike Mason - Chief Financial Officer
Jatin Shah - Senior Vice President, Clinical Development
Conference Call Participants
Maury Raycroft - Jefferies
Arlinda Lee - Canaccord Genuity
Eric Joseph - JPMorgan
Jonathan Chang - SVB Leerink
Presentation
Operator
Good morning. My name is Liz and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm